No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
303 |
4. Check minimum number of eventsNone |
303 |
5. Include endpointsNone |
303 |
6. Filter based on genotype QC (FinnGen only) |
303 |
Control definitions (FinnGen only)
- Control exclude
- SLE_FG
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M32
- Name in latin
- Aliae formae lupi erythematosi disseminati (LED)
Similar endpoints
↥List of similar endpoints to
Other forms of systemic lupus erythematosus
based on the number of shared cases.
Similar with more cases:
- SLE, strict definition
- SLE, ICD10
- Systemic lupus erythematosus
- SLE (Finngen)
- Systemic connective tissue disorders
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1584 | 1344 | 221 |
| Only index persons | 1393 | 1210 | 183 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.04 | 0.01 |
| Only index persons | 0.04 | 0.04 | 0.01 |
| Median age at first event (years) | |||
| Whole population | 48.85 | 48.53 | 50.99 |
| Only index persons | 47.72 | 47.64 | 48.24 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 303 | 265 | 38 |
| Unadjusted period prevalence (%) | 0.08 | 0.09 | 0.02 |
| Median age at first event (years) | 45.16 | 44.20 | 51.85 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 276
- Matched controls
- 2759
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M32.8
ICD-10 Finland
Other forms of systemic lupus erythematosus
+∞
323.0
270
*
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
+∞
288.8
224
*
P01BA02
ATC
hydroxychloroquine; oral
111.6
205.4
233
127
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
60.8
170.5
225
186
M32.1
ICD-10 Finland
Systemic lupus erythematosus with organ or system involvement
+∞
99.1
89
*
L04AX01
ATC
azathioprine; systemic
35.5
92.3
122
60
M32.0
ICD-10 Finland
Drug-induced systemic lupus erythematosus
+∞
90.7
82
*
7100A
ICD-9 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
+∞
79.0
72
*
M32
ICD-10 Finland
Systemic lupus erythematosus
+∞
56.2
52
*
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
14.4
55.8
102
108
L04AA06
ATC
mycophenolic acid; systemic
42.5
54.9
68
21
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
11.2
51.0
107
147
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
7.0
48.8
189
656
H02AB06
ATC
prednisolone; systemic
7.7
48.7
223
971
M35.9
ICD-10 Finland
Systemic involvement of connective tissue, unspecified
68.2
48.6
55
10
H02AB07
ATC
prednisone; oral
8.0
44.6
120
243
73410
ICD-8 Finland
Diffuse diseases of connective tissue, Systemic lupus erythematosus
502.8
44.5
43
*
M05BA04
ATC
alendronic acid; oral
9.9
39.4
86
120
L93.0
ICD-10 Finland
Discoid lupus erythematosus
212.6
36.7
37
*
N08.5*M32.1
ICD-10 Finland
Glomerular disorders in systemic lupus erythematosus
+∞
35.2
33
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
8.2
32.8
80
131
R50.9
ICD-10 Finland
Fever, unspecified
6.5
29.5
86
179
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
7.3
28.9
76
137
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
7.2
26.2
68
119
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
10.7
25.7
51
57
M35.1
ICD-10 Finland
Other overlap syndromes
59.5
23.5
27
5
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.7
23.4
159
742
H02AB04
ATC
methylprednisolone; systemic
4.8
23.2
89
248
M05.8
ICD-10 Finland
Other seropositive rheumatoid arthritis
8.4
22.4
51
72
C08CA05
ATC
nifedipine; systemic
7.7
21.4
52
81
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
14.1
21.1
36
29
L88
ICPC
Rheumatoid/seropositive arthritis
9.8
20.8
43
51
L04AA01
ATC
[U] ciclosporin; systemic
20.6
19.1
28
15
ZX120
NOMESCO Finland
Intravenous
5.4
18.0
58
130
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.7
17.9
66
172
B01AA03
ATC
warfarin; systemic
4.3
17.6
73
213
G73.7*M32.1
ICD-10 Finland
Myopathy in systemic lupus erythematosus
+∞
16.8
16
*
D68.8
ICD-10 Finland
Other specified coagulation defects
28.2
15.8
21
8
N08.5
ICD-10 Finland
Glomerular disorders in systemic connective tissue disorders
+∞
15.8
15
*
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.6
15.7
82
288
P01BA01
ATC
chloroquine; systemic
40.6
15.6
19
5
J99.1*M32.1
ICD-10 Finland
Respiratory disorders in systemic: lupus erythematosus
+∞
14.7
14
*
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
38.3
14.6
18
5
XX9XE
NOMESCO Finland
Other ultrasound examination
18.3
14.6
22
13
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.8
14.3
66
209
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
4.8
14.0
49
119
TPH04
NOMESCO Finland
Cathetrisation of vein
3.3
14.0
82
311
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.5
14.0
75
268
A02BC01
ATC
omeprazole; systemic
3.0
13.8
101
448
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
13.7
105
478
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
2.6
13.2
146
827
G05.8*M32.1
ICD-10 Finland
Encephalitis in systemic lupus erythematosus
+∞
12.6
12
*
F02.89*M32.8
ICD-10 Finland
Dementia in systemic lupus erythematosus
+∞
12.6
12
*
N02AX02
ATC
tramadol; systemic, rectal
2.6
12.6
137
761
J05AB11
ATC
valaciclovir; oral
3.4
12.5
67
237
L04AD01
ATC
ciclosporin; systemic
11.3
12.0
22
21
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
7.5
12.0
28
41
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.8
11.9
54
167
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
17.4
11.8
18
11
R06.0
ICD-10 Finland
Dyspnoea
2.8
11.8
91
411
J05AB01
ATC
aciclovir; systemic
2.8
11.8
89
398
B02.9
ICD-10 Finland
Zoster without complication
5.8
11.6
33
63
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.1
11.6
37
81
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.3
11.6
44
116
C03CA01
ATC
furosemide; systemic
2.9
11.5
83
360
J01MA12
ATC
levofloxacin; systemic
3.1
11.5
70
270
M05BA07
ATC
risedronic acid; oral
6.8
11.3
28
45
TNX00
NOMESCO Finland
Puncture and needle biopsy of soft tissue, unspecified region
14.7
11.1
18
13
R4120
NOMESCO Finland
Occupational therapy
5.1
11.1
35
76
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
6.5
10.9
28
47
B01AB05
ATC
enoxaparin; parenteral
2.5
10.7
102
516
73491
ICD-8 Finland
Diffuse diseases of connective tissue, Collagenosis NUD
+∞
10.5
10
*
1XC02
NOMESCO Finland
NA
33.9
10.4
13
*
D07AB08
ATC
desonide; topical
3.4
10.4
54
186
B07.9
ICD-10 Finland
Verruca simplex
6.6
10.3
26
43
E0000UV
ATC
NA
2.3
10.3
139
839
J01FF01
ATC
clindamycin; systemic
2.5
10.1
104
543
J01FA06
ATC
roxithromycin; oral
2.3
9.9
137
829
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
9.9
74
323
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.9
9.5
26
48
L01BB01
ATC
NA
+∞
9.4
9
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.5
9.4
46
151
A02BC02
ATC
pantoprazole; systemic
2.3
9.4
195
1413
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.4
9.1
33
83
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
9.0
49
171
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
4.3
9.0
33
84
L01AA01
ATC
cyclophosphamide; systemic
51.6
8.7
10
*
NH1AE
NOMESCO Finland
Ankle joint ultrasound examination
51.6
8.7
10
*
M05BB03
ATC
alendronic acid and colecalciferol; oral
7.3
8.7
20
29
B99
ICD-10 Finland
Other and unspecified infectious diseases
12.1
8.7
15
13
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
12.1
8.7
15
13
N32.9
ICD-10 Finland
Bladder disorder, unspecified
28.5
8.5
11
*
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
4.0
8.5
34
94
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.6
8.5
24
46
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
7.5
8.4
19
27
7108X
ICD-9 Finland
Diffuse diseases of connective tissue, Other specified diffuse diseases of connective tissue
+∞
8.4
8
*
E000001
ATC
NA
2.5
8.3
77
376
A02BC03
ATC
lansoprazole; oral
2.3
8.3
97
529
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.6
8.2
63
278
D07AC01
ATC
betamethasone; topical
2.2
8.1
110
642
A02BC05
ATC
esomeprazole; systemic
2.1
8.1
126
784
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
8.9
7.9
16
19
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
7.3
7.9
18
26
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
11.3
7.9
14
13
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
7.8
7.8
17
23
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
6.5
7.7
19
31
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.0
7.7
140
923
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
7.6
36
116
XPX04
NOMESCO Finland
Angioscopy
82.2
7.5
8
*
L93.1
ICD-10 Finland
Subacute cutaneous lupus erythematosus
+∞
7.3
7
*
69540
ICD-8 Finland
Erythematous condition, Lupus erythematosus
+∞
7.3
7
*
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.3
7.3
37
125
J01MA14
ATC
moxifloxacin; systemic
3.2
7.3
38
131
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.8
7.3
23
51
S01AX11
ATC
[U] ofloxacin; ophthalmic
6.9
7.2
17
26
A41.9
ICD-10 Finland
Sepsis, unspecified
5.9
7.2
19
34
M05BA01
ATC
etidronic acid; systemic
30.9
7.2
9
*
C08CA01
ATC
amlodipine; oral
2.2
7.1
88
489
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
7.1
75
386
J01MA02
ATC
ciprofloxacin; systemic
2.0
7.1
111
683
NF1AA
NOMESCO Finland
Hip X-ray examination
3.4
7.1
33
105
L04AA13
ATC
leflunomide; oral
5.7
7.1
19
35
Z50.1
ICD-10 Finland
Other physical therapy
4.1
7.0
26
68
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.4
7.0
33
106
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.5
7.0
60
280
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
4.8
6.9
22
49
H26.3
ICD-10 Finland
Drug-induced cataract
14.2
6.9
11
8
N02AA05
ATC
oxycodone; systemic
2.7
6.9
47
194
205
Kela drug reimbursment
Chronic hypertension
2.3
6.8
68
342
G73.7
ICD-10 Finland
Myopathy in other diseases classified elsewhere
41.1
6.8
8
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
4.1
6.8
25
65
L99
ICPC
Musculoskeletal disease other
6.2
6.7
17
29
D02BB01
ATC
betacarotene; oral
23.2
6.7
9
*
M05BX04
ATC
denosumab; parenteral
4.1
6.7
25
66
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
6.7
33
110
A07AA02
ATC
nystatin; oral
3.5
6.7
30
93
M81.9
ICD-10 Finland
Osteoporosis, unspecified
4.7
6.6
21
47
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.9
6.6
26
72
XCK00
NOMESCO Finland
Perimetry
3.6
6.6
28
83
C02CA01
ATC
prazosin; oral
14.7
6.4
10
7
J01DB01
ATC
cefalexin; oral
2.3
6.4
238
2007
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
3.9
6.4
25
69
R4110
NOMESCO Finland
Physiotherapy
2.1
6.3
85
487
M34.9
ICD-10 Finland
Systemic sclerosis, unspecified
18.5
6.3
9
5
N08.5*M31.1
ICD-10 Finland
Glomerular disorders in thrombotic thrombocytopenic purpura
+∞
6.3
6
*
6BA02
NOMESCO Finland
NA
27.3
6.3
8
*
UJF30
NOMESCO Finland
Ileoscopy through colon
2.9
6.2
37
140
H53.1
ICD-10 Finland
Subjective visual disturbances
3.4
6.2
29
93
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.7
6.2
42
171
B01AB04
ATC
dalteparin; parenteral
4.4
6.2
21
51
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
6.1
50
225
H26.2
ICD-10 Finland
Complicated cataract
12.9
6.1
10
8
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
5.4
6.1
17
33
N02AJ06
ATC
codeine and paracetamol; systemic
1.9
6.1
111
710
A46
ICD-10 Finland
Erysipelas
2.8
6.1
39
154
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
5.8
6.1
16
29
M01AH02
ATC
rofecoxib; oral
2.6
6.1
43
181
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
3.1
6.0
31
107
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
149
92
30.90
189.90
9.1
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
96
78
17.55
102.59
2.0
1.2
u/ml
29.0
2.5
—
36
9
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
95
80
16.84
99.30
2.0
1.2
u/ml
21.6
2.9
2.33
45
13
(3037522) Nuclear Ab [Titer] in Serum
170
390
8.65
80.69
2.6
1.4
titre
993.0
537.6
2.56
120
84
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
78
69
14.88
78.29
2.0
1.1
u/ml
61.9
40.5
—
25
7
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
55
47
14.08
55.65
1.4
1.2
u/ml
10.2
6.7
0.24
33
14
(42870588) Differential panel, method unspecified - Blood
210
792
6.38
53.86
13.4
5.0
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
267
1261
10.40
52.98
16.9
5.1
e9/l
0.0
0.0
0.24
257
1098
(3001604) Monocytes [#/volume] in Blood
266
1254
10.18
52.80
16.9
5.1
e9/l
0.6
0.5
0.97
256
1094
(3013115) Eosinophils [#/volume] in Blood
268
1310
10.05
49.93
17.3
5.4
e9/l
0.1
0.2
6.82
260
1159
(3019198) Lymphocytes [#/volume] in Blood
266
1299
9.58
49.33
17.1
5.0
e9/l
1.6
2.0
3.98
258
1156
(4268621)
43
31
16.00
47.73
2.3
2.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
51
50
12.06
47.06
1.4
1.2
u/ml
6.3
11.9
0.43
36
17
(3002030) Lymphocytes/100 leukocytes in Blood
255
1232
7.75
46.68
17.9
5.1
%
26.3
29.0
3.49
250
1141
(3013650) Neutrophils [#/volume] in Blood by Automated count
270
1472
8.66
40.26
19.9
8.5
e9/l
3.9
3.9
0.24
260
1297
(3002179) Metamyelocytes/100 leukocytes in Blood
82
175
6.05
38.66
6.4
4.1
%
0.5
0.7
0.31
24
35
(3017181) Myelocytes/100 leukocytes in Blood
87
200
5.70
37.77
7.5
4.0
%
0.6
0.9
0.49
33
55
(3021440) Promyelocytes/100 leukocytes in Blood
83
186
5.77
37.01
7.7
4.2
%
0.0
0.2
2.01
32
46
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
31
21
16.33
35.29
1.5
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
31
21
16.33
35.29
1.5
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
31
21
16.33
35.29
1.5
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
31
22
15.58
34.42
1.5
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
31
22
15.58
34.42
1.5
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
31
22
15.58
34.42
1.5
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
75
178
5.27
30.98
8.1
4.2
%
0.0
0.2
0.49
25
39
(3018095) Leukocytes [#/volume] in Urine
186
871
3.94
30.26
7.2
3.6
e6/l
130.1
75.9
0.42
150
595
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
212
1102
4.08
29.12
3.7
2.3
nmol/l
81.9
77.3
1.53
205
986
(3002582) Erythrocytes [#/volume] in Urine
160
717
3.61
27.01
6.0
3.0
e6/l
44.9
137.5
0.49
144
547
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
176
847
3.57
26.36
7.1
2.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
128
505
3.66
26.21
4.1
2.5
e6/l
4.4
7.9
1.33
115
452
(3026782) Osmolality of Urine
122
469
3.68
25.95
5.1
2.5
mosm/kgh2o
518.0
543.4
0.67
114
404
(3024561) Albumin [Mass/volume] in Serum or Plasma
191
984
3.55
25.31
6.7
4.0
g/l
34.2
36.4
6.20
181
922
(3030467) Casts [#/volume] in Urine by Automated count
147
648
3.46
25.04
5.9
2.8
e6/l
0.2
0.4
1.20
125
481
(3015736) pH of Urine
190
997
3.43
24.00
6.1
3.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
222
1290
3.70
23.58
7.8
3.5
estimate
0.0
0.0
0.00
45
247
(3037467) Urinalysis macro (dipstick) panel - Urine
266
1754
5.23
23.23
12.5
4.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
219
1270
3.61
23.15
7.7
3.5
estimate
0.0
0.0
0.00
43
252
(3021601) Nitrite [Presence] in Urine by Test strip
219
1277
3.58
22.79
11.2
4.8
estimate
0.0
0.0
0.50
45
254
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
23
20
12.36
22.49
1.1
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
129
558
3.28
22.11
5.7
3.8
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
205
1166
3.34
21.86
12.2
5.8
mmol/l
1.2
1.2
0.01
182
975
(3004616) Nuclear Ab [Presence] in Serum
29
37
8.56
21.65
1.8
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
148
706
3.14
21.28
2.5
2.0
u/l
95.3
259.9
1.08
142
664
(3034426) Prothrombin time (PT)
17
11
16.31
19.50
1.2
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
83
297
3.47
19.01
4.1
2.3
%
19.0
22.7
1.97
76
253
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
20
19
11.20
18.41
1.5
1.1
ratio
1.1
1.1
—
6
6
(3012544) pH of Venous blood
62
187
3.91
18.28
5.5
3.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
21
22
10.18
18.09
2.4
2.0
e9/l
0.7
0.9
—
14
6
(40760892) CBC W Ordered Manual Differential panel - Blood
130
621
2.92
17.98
11.8
4.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
148
762
2.84
17.71
3.6
2.9
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
189
1117
2.84
17.14
19.1
8.3
e9/l
0.0
0.0
0.09
174
908
(36304419) Bacteria [Presence] in Urine
132
650
2.83
17.06
5.3
2.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
82
312
3.23
16.82
3.3
1.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
91
370
3.09
16.65
5.0
2.5
e6/l
1.9
1.1
0.69
66
194
(3002032) Base excess in Venous blood by calculation
58
180
3.75
16.32
5.7
3.6
mmol/l
2.0
2.1
0.10
48
146
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
117
558
2.79
15.86
3.1
3.1
ng/l
1382.4
953.4
0.60
105
470
(3020630) Protein [Mass/volume] in Serum or Plasma
55
169
3.75
15.67
2.0
3.0
g/l
65.8
67.2
0.62
50
150
(3011397) Hemoglobin [Presence] in Urine by Test strip
117
562
2.76
15.60
5.3
3.5
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
85
350
2.99
15.05
5.4
2.7
e6/l
2.4
4.0
1.20
61
175
(3007853) Bacteria identified in Skin by Aerobe culture
68
248
3.25
14.82
2.5
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
23
35
7.03
14.69
2.5
3.4
%
1.5
1.7
0.08
16
25
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
117
582
2.65
14.34
3.1
2.0
mg/l
3.1
3.0
0.22
110
495
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
81
334
2.95
14.23
2.1
1.8
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
33
74
4.88
14.15
4.1
2.4
g/l
0.4
0.3
0.15
21
21
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
18
9.33
13.00
1.5
2.2
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
15
16
9.81
12.65
2.5
2.3
e9/l
0.0
0.2
2.58
15
16
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
18
9
21.16
12.61
2.5
2.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
48
156
3.47
12.47
1.6
1.7
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
43
130
3.69
12.45
5.7
3.0
e6/l
0.1
0.2
0.54
43
124
(3027945) Reticulocytes/100 erythrocytes in Blood
57
212
3.08
11.87
3.0
3.2
%
1.7
1.8
0.35
57
188
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
72
4.51
11.83
1.9
2.5
g/l
7.1
7.6
0.63
24
58
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
72
4.51
11.83
1.9
2.5
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
30
72
4.51
11.83
1.9
2.5
g/l
3.0
3.7
3.08
23
55
(3007164) IgA [Mass/volume] in Serum or Plasma
111
582
2.43
11.75
1.9
1.4
g/l
2.4
2.2
0.66
78
355
(3032080) INR in Blood by Coagulation assay
147
878
2.31
11.47
15.9
7.8
inr
1.4
1.1
1.59
32
287
(3022217) INR in Platelet poor plasma by Coagulation assay
64
259
2.86
11.45
40.0
16.6
inr
1.3
1.2
0.11
16
41
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
24
49
5.23
11.41
1.7
1.3
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
167
1056
2.30
11.33
10.5
5.2
mmol/l
1.2
1.2
0.54
161
955
(3012095) Magnesium [Moles/volume] in Serum or Plasma
77
345
2.65
11.31
4.8
3.1
mmol/l
0.8
0.8
0.21
71
325
(40758558) Short blood count panel - Blood
118
647
2.35
11.20
12.6
6.7
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
28
69
4.37
10.67
2.0
2.6
g/l
3.0
3.2
0.59
23
56
(3004588) Protein electrophoresis panel - Serum or Plasma
42
141
3.30
10.32
1.7
2.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
24
54
4.74
10.21
1.5
1.6
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
60
249
2.76
10.17
1.9
1.9
nmol/l
353.2
380.9
0.50
54
233
(3018418) pH of Serum or Plasma
124
727
2.19
9.74
6.6
3.9
ph
7.4
7.4
0.42
25
144
(3023520) Reticulocytes [#/volume] in Blood
43
152
3.13
9.69
1.7
3.0
e9/l
69.3
73.1
0.23
30
115
(3017354) Segmented neutrophils/100 leukocytes in Blood
15
23
6.81
9.44
2.8
2.7
%
61.8
54.3
—
8
12
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
17
7.95
9.34
1.5
2.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
125
747
2.15
9.25
8.0
3.1
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
50
4.67
9.24
2.8
2.5
u/ml
0.3
0.3
0.01
14
27
(3009508) Creatinine [Moles/volume] in Urine
117
682
2.17
9.22
5.3
2.9
mmol/l
7.0
7.5
0.59
105
581
(3017143) Hepatitis C virus Ab [Presence] in Serum
66
301
2.52
9.21
1.5
1.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
63
285
2.53
8.92
1.6
1.3
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
20
44
4.80
8.72
1.1
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
20
44
4.80
8.72
1.4
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
112
654
2.13
8.69
6.4
3.8
mg/mmol
25.7
7.8
1.15
87
385
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
153
1007
2.05
8.57
8.3
3.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
53
225
2.64
8.53
2.1
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
23
58
4.21
8.50
6.0
4.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
101
572
2.15
8.44
2.1
1.7
mg/l
1.6
0.9
1.28
82
442
(3019225) pH of Specimen
51
214
2.66
8.39
7.3
4.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
29
88
3.54
8.30
5.7
3.5
mmol/l
23.7
24.2
0.30
24
82
(3021788) Differential panel - Synovial fluid
17
34
5.24
8.24
1.8
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
38
4.97
8.22
1.2
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
26
74
3.75
8.17
1.7
1.6
iu/ml
0.2
0.0
—
6
11
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
21
51
4.35
8.14
1.3
1.9
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
52
224
2.60
8.11
2.1
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
134
857
2.01
7.98
4.4
3.4
ng/l
600.2
29.0
0.52
94
538
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
21
52
4.26
7.94
1.4
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
29
91
3.42
7.89
1.9
2.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
173
1213
1.99
7.88
4.3
2.8
ug/l
111.4
80.0
1.48
165
1127
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
62
3.93
7.78
1.4
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
32
108
3.19
7.77
1.2
1.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
182
1307
1.98
7.65
7.2
5.5
umol/l
9.4
9.8
0.34
176
1230
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
27
83
3.47
7.58
2.1
1.9
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
44
181
2.67
7.51
4.3
2.2
e9/l
3.3
4.1
1.16
36
151
(3012516) Albumin [Mass/volume] in Urine
103
613
2.03
7.39
5.5
3.0
mg/l
100.9
281.4
0.54
77
370
(21494814) CD8 cells/100 lymphocytes in Specimen
10
5
20.60
7.18
2.5
3.6
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
10
5
20.60
7.18
2.7
3.8
%
2.0
6.0
—
10
5
(3000991) Gas panel - Venous blood
39
155
2.74
7.10
13.5
6.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
20
52
4.05
7.10
6.5
3.9
%
59.7
57.8
0.26
20
52
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
26
82
3.37
7.02
1.3
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
13
24
5.61
6.83
2.8
4.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
65
338
2.18
6.58
2.2
2.2
ug/g
65.4
117.7
1.64
55
267
(3030905) Polymorphonuclear cells [#/volume] in Blood
19
51
3.91
6.47
6.7
3.5
e9/l
3.5
4.5
1.02
19
51
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
74
411
2.06
6.30
4.9
3.5
ng/l
368.9
143.4
0.79
54
292
(3014148) Varicella zoster virus Ab [Titer] in Serum
13
26
5.18
6.28
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
13
26
5.18
6.28
1.1
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
30
4.84
6.28
1.1
1.6
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
39
4.28
6.17
1.3
1.6
—
—
—
0
0
(44790048)
12
23
5.39
6.06
1.5
1.5
—
—
—
0
0
(44806118)
12
23
5.39
6.06
1.5
1.5
—
—
—
0
0
(44790049)
12
23
5.39
6.06
1.5
1.5
—
—
—
0
0
(44790047)
12
23
5.39
6.06
1.5
1.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
184
1387
1.83
6.04
7.1
4.0
mmol/l
6.2
6.5
1.18
177
1273
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
27
4.99
6.03
1.1
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
21
64
3.45
5.98
4.0
2.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
26
91
3.03
5.94
5.5
3.7
—
—
—
0
0
(44806071)
9
6
15.40
5.94
1.2
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
29
109
2.84
5.85
10.3
3.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
126
854
1.81
5.83
3.7
3.2
mmol/l
2.3
2.4
2.21
117
756
(46235355) HIV 1 and 2 tests - Meaningful Use set
86
519
1.92
5.73
1.5
1.9
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
37
4.21
5.69
1.3
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
75
434
1.97
5.64
1.6
1.7
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
7
13.20
5.61
1.0
1.7
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
40
181
2.39
5.58
1.4
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
18
52
3.62
5.54
3.5
2.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
25
4.96
5.54
1.3
1.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
117
785
1.80
5.54
2.7
2.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
28
107
2.78
5.49
2.1
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
14
34
4.27
5.42
1.2
1.6
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
17
48
3.69
5.40
1.2
1.5
u/ml
373.1
265.1
—
10
28
(3013512) EKG study
102
662
1.82
5.36
4.9
3.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
18
5.71
5.36
1.1
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
9
8
11.55
5.32
1.4
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
23
80
3.03
5.32
1.2
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
90
564
1.85
5.29
6.4
3.7
kg/l
1.0
1.0
0.04
14
78
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
286
2563
3.07
5.23
34.4
12.2
mg/l
17.3
20.9
1.74
256
1961
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
0
+∞
5.22
1.4
0.0
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
0
+∞
5.22
1.4
0.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
22
76
3.04
5.15
5.4
4.1
%
1.6
1.6
0.03
22
70
(3035285) Chloride [Moles/volume] in Venous blood
13
31
4.34
5.14
3.5
2.5
mmol/l
108.3
106.9
0.43
13
31
(3033705) Calcium.ionized [Moles/volume] in Venous blood
13
31
4.34
5.14
3.5
2.5
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
13
31
4.34
5.14
3.5
2.5
mmol/l
3.9
3.9
0.06
13
31
(3016018) Differential panel - Cerebral spinal fluid
10
19
5.41
5.07
1.2
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
17
51
3.47
4.96
1.2
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
29
120
2.57
4.89
1.6
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
92
595
1.78
4.82
4.2
2.6
umol/l
8840.7
8733.5
0.00
83
517
(3045424) Erythrocytes [Presence] in Urine
16
47
3.54
4.81
1.9
1.5
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
7
11.69
4.81
1.9
1.9
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
7
11.69
4.81
1.4
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
66
385
1.91
4.80
1.9
1.7
nmol/l
1202.5
1284.3
0.29
54
282
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
35
160
2.34
4.78
1.7
2.4
ug/l
8.5
5.1
0.52
30
141
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
33
4.07
4.76
1.4
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
17
53
3.34
4.69
1.4
1.5
—
—
—
0
0
(3009343) pH of Capillary blood
30
130
2.45
4.60
5.3
3.4
—
7.4
—
0
17
(4062490)
11
25
4.53
4.60
1.4
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
17
54
3.28
4.56
2.5
2.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
21
77
2.86
4.45
5.4
4.1
%
0.7
0.9
3.05
21
72
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
130
944
1.66
4.40
2.3
1.9
pmol/l
100.7
97.2
0.32
65
464
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
28
121
2.45
4.33
5.4
3.5
mmol/l
0.8
1.5
0.19
23
91
(36660697) Celiac disease serology panel - Serum
42
217
2.09
4.27
1.2
1.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
154
1175
1.63
4.24
4.9
3.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
88
584
1.71
4.14
2.7
2.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
7
7
10.20
4.03
2.9
2.1
ug/l
49.4
153.4
—
7
7
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
14
6.59
4.01
1.2
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
19
71
2.79
3.90
1.4
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
99
688
1.65
3.88
8.3
3.8
estimate
0.0
0.0
0.50
45
255
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
8
8.92
3.79
1.1
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
8
8.92
3.79
1.0
1.4
—
—
—
0
0
(4035726)
39
208
2.00
3.65
1.4
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
37
194
2.03
3.63
7.9
3.3
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
15
51
3.04
3.63
1.1
1.1
—
13.2
—
0
5
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
9
7.93
3.57
1.1
1.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
9
7.93
3.57
2.9
3.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
6
10.17
3.51
1.2
1.2
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
6
10.17
3.51
1.2
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
14
47
3.07
3.46
1.1
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
18
70
2.67
3.45
1.5
2.2
mg/l
9.4
10.0
0.18
18
64
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
27
128
2.22
3.42
1.8
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
32
163
2.08
3.39
3.1
2.8
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
10
27
3.80
3.38
1.5
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
7
10
7.13
3.38
6.1
1.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
13
43
3.11
3.29
1.3
1.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
9
19
4.85
3.26
1.2
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
14
49
2.95
3.23
1.4
1.4
—
111.0
—
0
12
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
9
20
4.60
3.13
1.2
1.7
umol/l
12.9
11.7
—
9
20
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
50
2.89
3.13
1.1
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
10
29
3.53
3.07
1.2
1.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
68
454
1.64
3.05
3.7
2.5
mmol/l
2.5
2.4
0.19
61
398
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
12
5.94
3.03
2.3
2.8
u/ml
367.3
713.7
—
7
12
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
37
207
1.90
3.03
3.8
2.5
ml/min/173m2
62.7
69.3
0.68
24
85
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
238
2099
1.62
3.01
4.6
4.3
pmol/l
14.6
14.5
0.25
228
1930
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
5
10.14
2.99
1.0
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
266
2419
1.82
2.95
25.5
11.1
ml/min/173m2
83.6
84.6
0.26
249
1950
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
17
4.80
2.94
1.3
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
41
3.01
2.89
1.8
1.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
13
5.48
2.88
1.1
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
9
6.77
2.88
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
20
91
2.28
2.80
1.3
1.4
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
6
8.45
2.76
1.2
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
7
14
5.09
2.74
2.0
4.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
11
37
3.05
2.72
1.3
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
11
37
3.05
2.72
1.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
11
37
3.05
2.72
1.3
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
10
6.09
2.71
1.3
2.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
10
6.09
2.71
1.3
2.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
8
19
4.29
2.69
1.1
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
19
4.29
2.69
1.4
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
24
3.83
2.69
1.6
1.3
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
32
3.20
2.67
1.3
1.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
54
352
1.65
2.65
1.3
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
200
1722
1.47
2.60
4.1
3.4
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
90
664
1.51
2.59
1.4
1.3
u/ml
1.0
2.1
1.00
23
203
(3044290) Cell count panel - Cerebral spinal fluid
13
50
2.67
2.56
1.5
1.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
77
552
1.53
2.53
1.6
1.5
nmol/l
19.5
22.2
0.91
68
457
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
6
12
5.08
2.41
1.3
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
14
58
2.48
2.40
1.6
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
12
46
2.68
2.39
1.3
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
12
46
2.68
2.39
1.3
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
13
4.68
2.28
2.0
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
13
4.68
2.28
1.5
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
13
4.68
2.28
1.5
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
13
4.68
2.28
1.5
1.9
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
6
13
4.68
2.28
1.2
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
6
13
4.68
2.28
1.2
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
13
4.68
2.28
1.5
1.9
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
18
3.95
2.26
1.1
1.4
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
9
5.63
2.22
5.6
4.1
u/l
188.0
207.3
—
5
9
(3000570) Elastase.pancreatic [Mass/mass] in Stool
16
74
2.23
2.19
1.6
1.4
ug/g
387.8
316.7
1.00
11
39
(40768804) Tissue Pathology biopsy report
133
1086
1.40
2.18
2.2
2.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
19
3.75
2.16
1.4
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
19
3.75
2.16
1.4
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
19
3.75
2.16
1.4
2.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
14
4.35
2.16
7.2
1.7
—
—
—
0
0
(4306422)
11
43
2.62
2.12
1.1
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
10
5.06
2.08
1.2
1.5
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
10
5.06
2.08
1.2
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
21
3.39
1.97
2.9
2.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
11
45
2.50
1.95
1.0
1.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
8
27
3.01
1.95
3.5
3.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
11
4.60
1.95
1.2
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
11
4.60
1.95
1.2
1.5
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
5
11
4.60
1.95
1.0
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
7
22
3.23
1.89
1.1
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
7
22
3.23
1.89
1.1
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
28
2.91
1.87
1.0
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
28
2.91
1.87
1.0
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
25
147
1.76
1.80
1.3
1.2
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
18
3.38
1.75
1.5
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
18
3.38
1.75
3.0
3.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
180
0.43
1.75
1.5
1.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
30
2.71
1.73
2.1
2.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
13
3.89
1.72
1.4
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
5
13
3.89
1.72
1.4
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
13
3.89
1.72
1.6
1.5
ug/l
13.9
31.8
—
5
13
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
70
532
1.41
1.68
1.4
1.3
iu/ml
42.1
31.7
0.40
28
178
(3020564) Creatinine [Moles/volume] in Serum or Plasma
284
2708
1.78
1.65
34.8
13.8
umol/l
81.0
70.6
2.04
284
2708
(3024891) Influenza virus A+B Ag [Presence] in Specimen
15
77
2.00
1.62
1.1
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
14
3.61
1.62
1.0
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
26
2.73
1.59
1.1
1.0
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
33
2.46
1.55
1.4
1.0
—
—
—
0
0
(4024509)
5
15
3.37
1.53
1.0
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
15
3.37
1.53
5.0
1.9
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
5
15
3.37
1.53
1.0
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
9
37
2.48
1.49
1.3
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
9
37
2.48
1.49
1.3
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
45
2.26
1.48
1.7
2.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
9
38
2.41
1.47
1.3
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
38
2.41
1.47
4.8
2.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
16
3.16
1.44
1.6
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
17
96
1.82
1.42
2.2
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
29
2.45
1.40
1.7
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
5
17
2.97
1.36
1.0
1.2
iu/ml
81.4
107.0
—
5
17
(3020717) Zinc [Moles/volume] in Serum or Plasma
5
17
2.97
1.36
1.0
1.1
umol/l
10.8
22.4
—
5
17
(3021901) Oxygen saturation in Capillary blood
9
42
2.18
1.35
1.6
2.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
192
1737
1.29
1.31
3.7
2.9
u/l
56.0
41.0
1.00
184
1643
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
34
2.39
1.30
1.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
18
2.81
1.29
1.0
1.4
g/l
1.0
1.0
—
5
18
(4027681)
5
18
2.81
1.29
1.8
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
284
2730
1.64
1.29
26.4
9.4
u/l
25.0
23.9
0.67
284
2635
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
34
239
1.48
1.25
4.7
3.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
8
37
2.19
1.22
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
5
19
2.66
1.22
1.0
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
19
2.66
1.22
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
185
0.52
1.20
1.2
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
38
2.13
1.19
1.0
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
8
38
2.13
1.19
1.1
3.8
umol/l
28.5
33.8
—
8
32
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
26
2.33
1.19
1.5
1.2
pg
32.7
32.2
—
6
26
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
28
191
1.51
1.19
2.9
3.8
pmol/l
4.2
4.7
1.37
23
169
(3005322) IgE [Units/volume] in Serum or Plasma
27
183
1.52
1.18
1.5
1.2
u/ml
42.2
147.1
3.31
22
167
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
10
50
2.03
1.18
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
39
2.08
1.16
1.0
1.0
—
—
—
0
0
(44813793)
5
20
2.52
1.15
1.0
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
61
483
1.33
1.14
1.5
1.7
pmol/l
407.7
29927457.3
0.78
54
411
(3019060) Gas panel - Arterial blood
20
127
1.62
1.14
2.9
3.9
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
197
1804
1.26
1.14
3.8
3.3
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
11
58
1.93
1.13
2.4
2.3
kpa
7.9
8.1
0.15
11
52
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
258
2447
1.37
1.13
5.7
5.0
mu/l
2.0
2.3
0.30
247
2272
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
12
66
1.85
1.10
1.3
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
17
105
1.66
1.08
1.1
1.4
miu/ml
162.7
268.1
—
7
53
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
243
2291
1.31
1.06
5.5
5.1
mmol/mol
37.9
38.9
1.30
233
2146
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
16
98
1.67
1.05
22.5
7.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
14
83
1.72
1.03
1.2
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
83
1.72
1.03
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
53
1.92
1.02
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
53
1.92
1.02
1.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
253
2404
1.32
1.00
4.3
3.7
mmol/l
1.3
1.2
0.75
239
2224
(3020891) Body temperature
13
77
1.72
0.96
4.5
3.5
—
—
—
0
0
(3000492) Spirometry study
32
235
1.40
0.96
1.5
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
14
85
1.68
0.96
1.4
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
6
27
2.25
0.94
6.0
1.9
%
73.3
54.6
—
6
27
(3023410) Appearance of Cerebral spinal fluid
6
28
2.17
0.92
1.3
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
105
0.47
0.90
3.0
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
64
529
1.27
0.88
1.3
1.3
u/ml
24.1
11.0
0.60
28
211
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
26
188
1.42
0.86
1.7
1.3
—
38.5
—
0
10
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
31
1.95
0.85
1.0
1.1
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
18
121
1.52
0.85
14.0
4.6
mmol/l
26.0
25.3
0.38
18
121
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
31
233
1.37
0.83
3.5
4.0
ug/l
6.4
6.8
0.05
23
191
(3049717) Cytology report of Urine Cyto stain
11
65
1.72
0.83
1.8
2.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
85
977
0.82
0.81
2.9
2.7
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
8
47
1.72
0.81
3.4
2.7
kpa
8.2
9.0
—
8
47
(40760888) Immunoglobulin light chains.free panel - Serum
8
47
1.72
0.81
1.6
6.1
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
8
47
1.72
0.81
3.4
2.7
kpa
5.2
5.1
—
8
47
(1616796) Gas panel - Central venous blood
8
48
1.68
0.79
2.1
2.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
38
298
1.31
0.79
4.2
4.0
%
32.9
32.4
0.14
33
194
(4010399)
24
175
1.40
0.77
1.3
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
37
291
1.31
0.75
1.4
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
107
0.55
0.74
1.7
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
21
285
0.72
0.73
1.3
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
5
25
2.02
0.73
1.2
2.1
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
5
25
2.02
0.73
1.8
1.8
mmol/l
6.8
7.3
—
5
16
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
78
674
1.21
0.73
1.9
1.6
mmol/l
1.4
1.4
0.05
71
572
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
143
0.62
0.71
1.2
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
27
1.87
0.68
2.0
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
29
224
1.33
0.68
14.7
5.7
mmol/l
0.7
1.3
0.42
22
181
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
260
2510
1.25
0.66
4.9
4.2
mmol/l
4.5
4.8
6.39
249
2342
(3022806) Fractional oxyhemoglobin in Capillary blood
5
28
1.80
0.66
1.6
1.8
%
88.7
90.1
—
5
28
(3032773) Endomysium IgG Ab [Titer] in Serum
5
28
1.80
0.66
1.0
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
28
1.80
0.66
2.0
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
28
1.80
0.66
1.0
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
259
2500
1.25
0.66
4.8
4.1
mmol/l
1.5
1.6
1.59
247
2323
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
263
2546
1.25
0.62
5.1
4.6
mmol/l
2.6
2.8
6.55
252
2362
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
30
1.68
0.61
1.6
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
20
265
0.74
0.61
1.3
1.7
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
10.5
—
0.7
—
0
21
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
7
111
0.62
0.59
1.6
1.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
115
1.41
0.58
2.2
2.4
—
—
—
0
0
(1002224) Polysomnography panel
8
122
0.65
0.56
1.3
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
98
0.60
0.53
1.5
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
20
154
1.32
0.50
1.1
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
24
299
0.79
0.49
1.8
1.9
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
7
50
1.41
0.45
2.1
1.8
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
51
1.38
0.44
1.1
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
27
222
1.24
0.42
8.2
3.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
15
114
1.33
0.41
1.1
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
33
1.52
0.41
1.0
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(4198724)
0
16
0.00
0.41
0.0
1.9
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
17
0.00
0.41
0.0
1.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
34
1.48
0.40
1.8
1.1
nmol/l
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.0
—
0.3
—
0
6
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
35
1.44
0.39
2.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
192
0.77
0.39
1.2
1.5
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.1
—
0.2
—
0
8
(21494890) Protein electrophoresis panel - 24 hour Urine
0
19
0.00
0.39
0.0
3.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
12
89
1.36
0.38
1.3
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
274
2689
1.20
0.37
24.4
11.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
11
145
0.75
0.35
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
13
167
0.77
0.35
1.5
1.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
25
210
1.21
0.34
2.0
2.8
u/ml
44.6
41.6
0.06
25
199
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
56
1.26
0.29
1.3
1.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
8
64
1.26
0.27
6.1
5.9
mmol/l
1.3
1.1
—
8
56
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
67
1.20
0.26
1.6
1.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
77
1.31
0.26
1.2
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
20
171
1.18
0.24
2.1
1.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.2
—
0.5
—
0
5
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
17.3
—
0
10
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
12
0.00
0.21
0.0
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
12
0.00
0.21
0.0
2.7
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.1
—
0
6
(3047189) Immunofixation for 24 hour Urine
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3004451) EKG impression Narrative
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
52
1.16
0.19
1.2
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
15
129
1.17
0.17
1.5
2.2
u/l
9790.3
4163.2
—
7
51
(3019832) Treponema pallidum Ab [Presence] in Serum
28
307
0.90
0.16
1.5
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
78
0.76
0.15
1.5
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
78
0.76
0.15
1.2
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
248
2449
1.07
0.14
4.8
4.1
mmol/l
5.4
5.8
7.47
235
2266
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
56
587
0.94
0.12
1.6
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
66
635
1.05
0.10
1.8
1.5
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
46
1.09
0.09
1.4
1.1
—
1.7
—
0
26
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
33
347
0.95
0.07
1.5
1.9
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
8
74
1.08
0.07
2.6
2.2
nmol/l
6.5
12.5
—
8
67
(4034850)
7
81
0.86
0.07
38.7
6.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
31
295
1.06
0.07
1.6
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
34
325
1.05
0.06
1.2
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
24
227
1.06
0.06
2.3
1.7
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
239
2373
1.03
0.06
31.3
12.7
%
36.6
39.8
4.16
183
1821
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
37
384
0.96
0.05
1.5
2.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
110
0.91
0.05
1.5
1.4
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
10
110
0.91
0.05
1.5
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
26
249
1.05
0.04
1.2
1.3
iu/ml
106.9
180.8
—
9
115
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
109
0.91
0.04
1.0
1.9
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
15
158
0.95
0.02
2.5
4.7
%
20.6
21.7
—
7
67
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
28
287
0.97
0.01
8.7
5.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
71
704
1.01
0.00
1.6
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
11
111
0.99
0.00
1.5
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
111
0.99
0.00
1.5
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
10
105
0.95
0.00
1.5
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
166
1.03
0.00
1.4
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
14
136
1.03
0.00
1.6
1.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
15.2
—
0
5
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
1.6
—
0
5
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
5
0.00
0.00
0.0
2.2
—
1.2
—
0
5
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
0
8
0.00
0.00
0.0
2.0
—
1.2
—
0
8
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
88
0.91
0.00
1.6
1.5
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
7
69
1.01
0.00
2.4
2.9
mmol/l
3.7
3.9
—
7
62
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806420)
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
72
0.97
0.00
1.3
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint SLE_OTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| SLE_OTH | 2.654 [2.26, 3.11] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.168 |
During the follow-up period (1.1.1998 — 31.12.2019), 283 out of 1188 females with SLE_OTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| SLE_OTH | 2.679 [1.67, 4.29] | < 0.001 |
| Birth year | 0.988 [0.98, 1.0] | 0.01 |
During the follow-up period (1.1.1998 — 31.12.2019), 58 out of 186 males with SLE_OTH died.
Mortality risk
Mortality risk for people of age
years, who have SLE_OTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.202% | 0.566% |
| 5 | 1.436% | 2.969% |
| 10 | 3.668% | 7.89% |
| 15 | 7.028% | 14.305% |
| 20 | 12.148% | 23.574% |
Relationships between endpoints
↥Index endpoint: SLE_OTH – Other forms of systemic lupus erythematosus
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data